Open AccessA comparison between radiofrequency ablation combined with transarterial chemoembolization and surgical resection in hepatic carcinoma: A meta-analysis
Author(s) -
Hongye Wang,
Yihai Liu,
Kangjie Shen,
Yulan Dong,
JinYu Sun,
Yimei Shu,
Xiaojie Wan,
Xiaohan Ren,
XiaoHong Wei,
Bo Zhai
Publication year - 2019
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_503_19
Subject(s) - medicine , hazard ratio , radiofrequency ablation , relative risk , confidence interval , meta analysis , hepatocellular carcinoma , gastroenterology , retrospective cohort study , proportional hazards model , combination therapy , surgery , ablation
This study determined whether the effect of combination therapy for hepatic carcinoma (HCC) is comparable to surgical resection (SR). According to the guidelines of the American Association for the Study of Liver Disease, radiofrequency ablation (RFA) and SR are recommended for early HCC. However, patients treated with RFA had worse long-term survival than those who received SR. Many studies utilizing the combination therapy with RFA and transarterial chemoembolization (TACE) have reported better prognosis as compared to RFA alone.